WallStreetZenWallStreetZen

NASDAQ: HRMY
Harmony Biosciences Holdings Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Harmony Biosciences Holdings earnings were $180.9M for the trailing 12 months ending Jun 30, 2025, with 59.6% growth year over year. The latest HRMY earnings report on Jun 30, 2025 announced Q2 2025 earnings of $39.8M, down 12.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HRMY reported annual earnings of $145.5M, with 12.9% growth.

HRMY past earnings growth

How has HRMY's earnings growth performed historically?

Company
59.6%
Industry
31.66%
Market
30.36%
HRMY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HRMY's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HRMY's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HRMY earnings history

Current Revenue
$772.5M
Current Earnings
$180.9M
Current Profit Margin
23.4%

HRMY Return on Equity

Current Company
26.3%
Current Industry
-8.3%
Current Market
27.2%
HRMY's Return on Equity (26.3%)... subscribe to Premium to read more.
High Return on Equity Performance

HRMY undefined

Current Company
17.7%
Current Industry
1.1%
HRMY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HRMY announces earnings.

HRMY undefined

Current Company
25.99%
Current Industry
8.5%
HRMY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HRMY vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HRMY$265.05M$180.90M+13.41%$3.16
GLPGN/AN/AN/AN/A
IRON-$142.05M-$145.39MN/A-$4.47
DNLI-$466.91M-$479.03MN/A-$2.81
AGIO$711.54M$650.08M-15.73%$11.45
View Top Biotech Stocks

Harmony Biosciences Holdings Earnings Reports & History FAQ

What were Harmony Biosciences Holdings's earnings last quarter?

On HRMY's earnings call on Invalid Date, Harmony Biosciences Holdings (NASDAQ: HRMY) reported Q2 2025 earnings per share (EPS) of $0.69, up 245% year over year. Total HRMY earnings for the quarter were $39.78 million. In the same quarter last year, Harmony Biosciences Holdings's earnings per share (EPS) was $0.20.

If you're new to stock investing, here's how to buy Harmony Biosciences Holdings stock.

Is Harmony Biosciences Holdings profitable or losing money?

As of the last Harmony Biosciences Holdings earnings report, Harmony Biosciences Holdings is currently profitable. Harmony Biosciences Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $180.90 million, a 57.32% increase year over year.

What was HRMY's earnings growth in the past year?

As of Harmony Biosciences Holdings's earnings date in Invalid Date, Harmony Biosciences Holdings's earnings has grown 59.6% year over year. This is 27.94 percentage points higher than the US Biotechnology industry earnings growth rate of 31.66%. HRMY earnings in the past year totalled $180.90 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.